Logotipo del repositorio
  • Español
  • English
  • Iniciar sesión
    Ayuda

    Instrucciones:

    El Repositorio Institucional Académico (RIA) de la Universidad Andrés Bello, es un recurso de acceso abierto. No obstante, y de acuerdo con la ley chilena vigente sobre propiedad intelectual, mantiene en acceso restringido diversos documentos, los cuales sólo pueden ser consultados por la comunidad universitaria registrada. Para poder acceder a éstos, verificar el tipo de usuario y método de acceso, siguiendo las instrucciones que se detallan a continuación:

    • Si eres investigador, docente o funcionario con correo @unab.cl, ingresa utilizando tu usuario de computador o intranet (nombre de usuario sin incluir @unab.cl) y clave.
    • Si eres alumno, profesor adjunto o exalumno con correo @uandresbello.edu, debes registrarte primero, pinchando donde dice Nuevo usuario. Una vez registrado y obtenida el alta, ingresa con el correo electrónico institucional y la clave elegida. El registro se debe realizar utilizando la cuenta de correo institucional, no serán válidas cuentas gmail, hotmail o cualquier otro proveedor.
    • Si eres usuario externo, contactar directamente a repositorio@unab.cl
    o
    ¿Nuevo Usuario? Pulse aquí para registrarse¿Has olvidado tu contraseña?
  • Comunidades
  • Todo RIA
  • Contacto
  • Procedimientos de publicaciónDerecho de autorPolíticas del Repositorio
  1. Inicio
  2. Buscar por autor

Examinando por Autor "Beckhaus, Andrea A."

Mostrando 1 - 2 de 2
Resultados por página
Opciones de ordenación
  • Cargando...
    Miniatura
    Ítem
    Evaluation of monoclonal antibodies that detect conserved proteins from Respiratory Syncytial Virus, Metapneumovirus and Adenovirus in human samples
    (Elsevier B.V., 2018-04) González, Liliana A.; Vázquez, Yaneisi; Mora, Jorge E.; Palavecino, Christian E.; Bertrand, Pablo; Ferrés, Marcela; Contreras, Ana M.; Beckhaus, Andrea A.; Riedel, Claudia; Bueno, Susan M.
    Human Respiratory Syncytial Virus (hRSV), human Metapneumovirus (hMPV) and Adenovirus (ADV), are three of the most prevalent viruses responsible for pneumonia and bronchiolitis in children and elderly worldwide, accounting for a high number of hospitalizations annually. Diagnosis of these viruses is required to take clinical actions that allow an appropriate patient management. Thereby, new strategies to design fast diagnostic methods are highly required. In the present work, six monoclonal antibodies (mAbs, two for each virus) specific for conserved proteins from hRSV, hMPV and ADV were generated and evaluated through different immunological techniques, based on detection of purified protein, viral particles and human samples. In vitro evaluation of these antibodies showed higher specificity and sensitivity than commercial antibodies tested in this study. These antibodies were used to design a sandwich ELISA tests that allowed the detection of hRSV, hMPV, and ADV in human nasopharyngeal swabs. We observed that hRSV and ADV were detected with sensitivity and specificity equivalent to a current Direct Fluorescence Assay (DFA) methodology. However, hMPV was detected with more sensitivity than DFA. Our data suggest that these new mAbs can efficiently identify infected samples and discriminate from patients infected with other respiratory pathogens. © 2018 The Authors
  • No hay miniatura disponible
    Ítem
    Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections
    (Oxford University Press, 2022-10) Bertrand, Pablo J.; Vázquez, Yaneisi; Beckhaus, Andrea A.; González, Liliana A.; Contreras, Ana María; Ferres, Marcela; Padilla, Oslando; Riedel, Claudia A.; Kalergis, Alexis M.; Bueno, Susan M.
    Lower respiratory tract infections (LRTIs) produced by viruses are the most frequent cause of morbidity and mortality in children younger than 5 years of age. The immune response triggered by viral infection can induce a strong inflammation in the airways and cytokines could be considered as biomarkers for disease severity as these molecules modulate the inflammatory response that defines the outcome of patients. Aiming to predict the severity of disease during respiratory tract infections, we conducted a 1-year follow-up observational study in infants who presented upper or lower respiratory tract infections caused by seasonal respiratory viruses. At the time of enrollment, nasopharyngeal swabs (NPS) were obtained from infants to measure mRNA expression and protein levels of IL-3, IL-8, IL-33, and thymic stromal lymphopoietin. While all cytokines significantly increased their protein levels in infants with upper and lower respiratory tract infections as compared to control infants, IL-33 and IL-8 showed a significant increase in respiratory syncytial virus (RSV)-infected patients with LRTI as compared to patients with upper respiratory tract infection. We also found higher viral loads of RSV-positive samples with a greater IL-8 response at the beginning of the symptoms. Data obtained in this study suggest that both IL-8 and IL-33 could be used as biomarkers for clinical severity for infants suffering from LRTIs caused by the RSV. © 2022 The Author(s). Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved.